Provided by Tiger Trade Technology Pte. Ltd.

EVEREST MED

31.520
+1.9206.49%
Volume:10.17M
Turnover:328.84M
Market Cap:11.16B
PE:-35.42
High:33.520
Open:31.500
Low:31.020
Close:29.600
52wk High:55.900
52wk Low:22.700
Shares:354.00M
HK Float Shares:354.00M
Volume Ratio:7.14
T/O Rate:2.87%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.890
ROE:-1.18%
ROA:-1.06%
PB:1.82
PE(LYR):-35.42
PS:3.95

Loading ...

Movement Alert|EVEREST MED Rises 8.11% in Regular Trading, Former Moderna Scientists Join to Accelerate Global mRNA Clinical Development

Market Focus
·
3 hours ago

Everest Medicines Surges Over 12% in Morning Trading as Company Accelerates Global mRNA Strategy

Deep News
·
3 hours ago

mRNA Vaccine Hires Could Be A Game Changer For Everest Medicines (SEHK:1952)

Simply Wall St.
·
Yesterday

Everest Medicines (SEHK:1952) Forms ESG Committee, Is The Stock 32% Undervalued?

Simply Wall St.
·
Oct 09

Everest Medicines Appoints Ex-Moderna Executive Lakshmi Srinivasan as Head of Translational Medicine

Reuters
·
Oct 09

Everest Medicines Opens Up Over 5%, Appoints Two Moderna Oncology Vaccine Scientists to Accelerate Global mRNA Clinical Development

Deep News
·
Oct 09

Movement Alert|EVEREST MED Rises 5.21% in Regular Trading, Two Former Moderna mRNA Talents Join

Market Focus
·
Oct 09

Everest Medicines Welcomes Two Top mRNA Experts to Accelerate Global Innovation Strategy

Stock News
·
Oct 09

Movement Alert|EVEREST MED Falls 6.17% in Regular Trading, Biotech Sector Retreat Weighs

Market Focus
·
Oct 07

Movement Alert | EVEREST MED Rises 5.07% in Regular Trading, Broker Upgrade and Strong Nefecon Sales Drive Gains

Market Focus
·
Oct 06

Movement Alert|EVEREST MED Falls 5.04% in Regular Trading, Biotech Sector Pulls Back After Prior Session mRNA Rally

Market Focus
·
Oct 02

Movement Alert|EVEREST MED Falls 6.7% at Open, Pulling Back After Previous Sessions Strong Rally on Innovative Drug and mRNA Sector Gains

Market Focus
·
Oct 02

Everest Medicines Stock In Focus After China Approval For CARDAMYST

Simply Wall St.
·
Oct 01

Hong Kong Stock Movers: mRNA Concept Stocks Lead Gains, CanSinoBIO (06185) Surges Over 17% as Moderna's mRNA Neoantigen Therapy Set to Debut at ESMO Congress

Stock News
·
Sep 30

Movement Alert|EVEREST MED Rises 5.72% in Regular Trading, Medical Industry Policy and mRNA Pipeline Progress Boost Sentiment

Market Focus
·
Sep 30

Everest Medicines Sets Up ESG Committee, Names Four Directors Including Chairman Yifang Wu

Bulletin Express
·
Sep 28

Everest Medicines Establishes ESG Committee to Strengthen Sustainability Governance

Bulletin Express
·
Sep 28

Everest Medicines Forms ESG Committee

Stock News
·
Sep 28

Movement Alert|EVEREST MED Declines 5.04% in Regular Trading, Trading at HK$27.54

Market Focus
·
Sep 24

HK Movers | Biotech Names Firmed: CANSINOBIO up Nearly 10%, JW THERAP-B up More Than 7%

Tiger Newspress
·
Sep 23